Navigation Links
New Wireless ID Skin Patch Technology Designed to Reduce Medical Errors
Date:11/5/2007

WASHINGTON and GLASGOW, Scotland, Nov. 5 /PRNewswire/ -- Medical errors may soon be a relic of the past. Smart, wireless, RFID skin patches for identification and diagnostic applications are now being manufactured by Frank Sammeroff Ltd., who has formed a strategic alliance with Gentag, Inc. for the production of the patches.

"By combining cell phones with RFID skin patches, we feel that medical errors in hospitals worldwide can be reduced significantly, resulting in major cost benefits," announced Dr. John Peeters, the founder of Gentag.

"Our unique, patented, non-invasive solution combines disposable skin patches with RFID tags and cell phones and will allow physicians and nurses to use their cell phones or wireless PDAs to update medical charts, time of patient visit, drug administration, and also be immediately warned about possible drug interactions, prior to drug delivery.

"It is anticipated that these RFID skin patches and matching cell-phone software will be competitively priced to allow hospitals worldwide to use the technology."

"Frank Sammeroff Ltd. is pleased to add this innovative technology to its product portfolio," Lawrence Sammeroff, the chairman of the company said, adding, "We expect large quantities of RFID skin patches to be sold to hospitals but also to organizations such as amusement parks, where the ID skin patches could be used for entrance control, payment services, and for child identification and child location. Sammeroff will market the smart skin patches under its own label and will also offer private-label production."

The smart skin patches are thin, flexible, and wash proof, thus allowing comfortable wear for anyone. The skin patches allow for writing on them by pen, as well as writing data to the chip or to a remote website.

Gentag, Inc. is a technology development company focusing on the creation of innovative, low-cost, wireless sensor technologies based on cell phones. The company owns a unique intellectual property IP portfolio relating to cell- phone sensor combinations and wireless sensor networks.

Frank Sammeroff Ltd. is a leading manufacturer of surgical dressings and other healthcare products. The company was established in 1939.

For media inquiries please contact Marc Onigman at (617) 413-2830 (Gentag) or Lawrence Sammeroff (Chairman of Frank Sammeroff Ltd) at lawrence@sammeroff.co.uk

For commercial inquiries please contact either lawrence@sammeroff.co.uk or info@gentag.com for pricing, licensing, and distribution options.

For more information, visit http://www.gentag.com/ and http://www.sammeroff.co.uk


'/>"/>
SOURCE Gentag, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
2. Purdue creating wireless sensors to monitor bearings in jet engines
3. Valeritas Hires Trade and Distribution Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
4. Valeritas Hires Senior Account Management Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
5. Australian Therapeutics Goods Administration Approval for ActiPatch Achieved
6. Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers Diarrhea Patch at Keystone Conference
7. Korean Food and Drug Administration Approval for ActiPatch Achieved
8. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
9. Novel Technology Breaks Through Cancer Pain
10. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
11. Advanced Cell Technology Announces Proposed Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... June 23, 2016 ReportsnReports.com ... report to its pharmaceuticals section with historic and ... and much more. Complete report on ... pages, profiling 15 companies and supported with 261 ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global Cell ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):